WISDOM study seeks support from women to modernize breast screening guidelines

WISDOM study seeks support from women to modernize breast screening guidelines

Press releases may be edited for formatting or style | February 05, 2020 Women's Health
The WISDOM study, a groundbreaking effort to determine the optimal guidelines for breast cancer screening, is seeking all qualifying women across the country who wish to participate in improving breast cancer screening and prevention.

The recent nation-wide expansion of WISDOM offers all women - regardless of where they live, where they receive their health care, or their health insurance type the opportunity to participate in groundbreaking research and receive screening recommendations. The study seeks to enroll 100,000 women of all backgrounds to participate in an online study and compares two different approaches to breast cancer screening: annual mammography versus a personalized approach based on risk. The results of the study aim to optimize breast cancer screening protocols and improve treatment for millions of women and future generations of women.

Participation in the WISDOM study demonstrates personal commitment and support of World Cancer Day’s "I Am and I Will" campaign, an empowering movement uniting the world to fight against cancer through awareness and education.

Servicing GE/Siemens Nuclear Medicine equipment with OEM trained engineers

Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.

"World Cancer Day’s campaign reminds us of the power of individual action taken now to impact the future," said Dr. Olufunmilayo I. Olopade, M.D., FACP, director of the Center for Clinical Cancer Genetics & Global Health at University of Chicago Medicine. "Breast cancer is a unique disease with many types of treatment pathways. We need to better understand how we can effectively detect and prevent different types of breast cancer across a large and diverse population of women. With the WISDOM study, we are seeking a diverse group of women to take action and to participate in a trial that will influence screening standards and improve treatment for generations to come."

The WISDOM study will follow volunteers over time to determine whether a personalized risk-based approach to breast cancer screening can improve prevention and clinical outcomes for women when compared to the current, one-size-fits-all approach using standard annual mammograms.

Participation in the WISDOM study is free, and open to all women ages 40-74 who HAVE NOT been diagnosed with breast cancer. Participants may opt to be assigned at random to one of the study groups, or choose to be assigned to one of two study groups with different screening protocols:

Annual mammogram screenings – the current gold standard of care.
Personalized screening schedule based on factors including family history, genetics, lifestyle, and breast density.

You Must Be Logged In To Post A Comment